NEUROD1 and pancreatic ductal adenocarcinoma: We then quantified the expression of NeuroD1 protein in another 120 pancreatic ductal adenocarcinomas present in patients treated at our center, categorizing them into high and low NeuroD1 expression groups (Figs. 1K and S1B).